US-backed vaccine trial on babies canceled after international outcry
The decried trial was canceled last week before police seized vaccine doses.
Guinea-Bissau's government has formally rejected a clinical trial involving the hepatitis B vaccine for newborns, according to Danish researchers and US funding. The trial, proposed by the Bandim Health Project and the University of Southern Denmark, aimed to investigate potential nonspecific harms from the newborn dose of the vaccine.
The vaccine is universally recommended for all newborns and has a long history of safe and effective use. The rejection was communicated to Ars Technica by lead researcher Christine Stabell Benn. The decision came after a raid by Guinea-Bissau's judicial police on the Bandim Health Project's offices, resulting in the seizure of vaccines. The raid occurred following the trial's rejection.
Written by urgent.news from Ars Technica Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
